Skip to main content
PNTGThe Pennant Group, Inc.Sell5.6·$38.75+3.72%
SellModerate Confidence
Investment thesis

The Pennant Group is a healthcare services provider with 36% revenue growth and strong analyst consensus support, but a quality score of 3.4 out of 10 below the investable floor, an elevated put/call ratio of 6.00, and an asymmetry ratio of 0.74 that does not justify new risk at current prices near $33.

Thesis pillars

  • Quality Below Investable FloorStable
  • Strong Revenue Growth RateStable
  • Institutional Accumulation SignalStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

The Pennant Group, Inc. (PNTG) Stock Analysis

SellModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Engine safety override at $38.75: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.6/10. Specifically: Below-average business quality.

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and... Read more

$38.75+0.3% A.UpsideScore 5.6/10#15 of 36 Medical Care Facilities
QualityF-score6 / 9FCF yield1.43%
Stop $35.82Target $38.63(resistance)A.R:R -0.5:1
Analyst target$40.83+5.4%6 analysts
$38.63our TP
$38.75price
$40.83mean
$42

Sell if holding. Engine safety override at $38.75: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.6/10. Specifically: Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.6/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 33d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-06

Recent Developments — The Pennant Group, Inc.

Generated 2026-07-06T05:40:27Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Aug 5, 202633d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Target reached (-7.8% upside)
Quality below floor (3.4 < 4.0)

Key Metrics

P/E (TTM)44.8
P/E (Fwd)24.2
Mkt Cap$1.3B
EV/EBITDA28.2
Profit Mgn3.0%
ROE10.0%
Rev Growth36.0%
Beta1.25
DividendNone
Rating analysts13

Quality Signals

Piotroski F6/9

Options Flow

P/C0.75neutral
IV73%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Net Margin
1.5
Operating Margin
2.4
Roa
2.7
Roe
3.3
Current Ratio
4.6
Fcf Quality
4.9
Moat
4.9
Piotroski F
6.7
Earnings quality warning: 63% FCF/NINo competitive moat

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
2.7
Quality Rank
4.0
Growth Rank
8.3
Industry growth leader

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.9
Gap
5.0
52w Position
9.5
GatesA.R:R -0.5=NEGATIVEMomentum 8.5>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 33d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
86 · Overbought
20D MA 50D MA 200D MAGOLDEN CROSSSupport $29.66Resistance $39.42

Price Targets

$36
$39
A.Upside-0.3%
A.R:R-0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-7.8% upside)
! Quality below floor (3.4 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-05 (33d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is PNTG stock a buy right now?

Sell if holding. Engine safety override at $38.75: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.6/10. Specifically: Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $35.82. Score 5.6/10, moderate confidence.

What is the PNTG stock price target?

Take-profit target: $38.63 (+0.3% upside). Prior stop was $35.82. Stop-loss: $35.82.

What are the risks of investing in PNTG?

Target reached (-7.8% upside); Quality below floor (3.4 < 4.0).

Is PNTG overvalued or undervalued?

The Pennant Group, Inc. trades at a P/E of 44.8 (forward 24.2). TrendMatrix value score: 4.3/10. Verdict: Sell.

What do analysts say about PNTG?

13 analysts cover PNTG with a consensus score of 4.4/5. Average price target: $41.

What does The Pennant Group, Inc. do?The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and...

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.

Related stocks: NUTX (Nutex Health Inc.) · TOI (The Oncology Institute, Inc.) · UHS (Universal Health Services, Inc.) · SRTA (Strata Critical Medical, Inc.) · ARDT (Ardent Health, Inc.)
Home Stocks PNTG

Latest news

Latest News

Benzinga54d ago
Benzinga59d ago
Benzinga59d agoAnalyst
Benzinga59d agoAnalyst
Benzinga60d agoEarnings
Benzinga60d ago
Benzinga63d agoMerger Acquisition